Company news

Share this article:
Medical device company Uroplasty announced plans to double its US sales force by the end of its fiscal 2009, which began April 1, 2008. “We have successfully launched our second generation Urgent PC neuromodulation system in the US and in fiscal 2008 built a domestic sales force that has generated significant year-to-date sales growth,” said CEO David Kaysen, in a statement.  The sales team is expected to increase from 18 to 36 by March 31, 2009.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.

Insurers get personal to nip costs

Healthcare insurers seek to curb diabetes costs with interventions that may include house calls.

Novartis dials down RNA research

The drugmaker says the therapeutic approach has a narrow treatment potential.